# Acadia Pharmaceuticals Inc. – FDA Inspection, Feb 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/acadia-pharmaceuticals-inc/a5ee1d2d-f85e-40e7-a860-6147f71960c4
Source feed: FDA_Inspections

> FDA inspection 965150 of Acadia Pharmaceuticals Inc., February 17, 2016. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965150
- Company Name: Acadia Pharmaceuticals Inc.
- Inspection Date: 2016-02-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1135361 - 2021-01-27

Company: https://www.keypedia.com/companies/acadia-pharmaceuticals-inc/28c1a8c0-e128-4d10-ac29-27aa95b67b55

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c